Thomas D. Boyer Liver Institute

11/03/2025

Happy November! Check out the latest at the Thomas D. Boyer Liver Institute on our monthly newsletter.

November Newsletter -

The Boyer Liver Institute, launched in 2000, is dedicated to research, education, diagnosis and treatment of all forms of liver disease.  Stay updated with us to know about current studies, free Hep-C testing, and more! Care for patients suffering from liver disorders such as Hepatitis B, Hepatitis...

10/31/2025

Happy Halloween! Yesterday, the Hepatitis C team had the privilege to participate in a hosted by the Consulmex Douglas. Thank you for having us at the fair, and make sure to be safe and get screened for Hepatitis C.¡Feliz Halloween! Ayer, el equipo de Hepatitis C pudo participar en una organizada por el Consulmex Douglas. Gracias por invitarnos a la feria, ¡y no olviden cuidarse y hacerse la prueba de Hepatitis C!

10/29/2025

For Liver Awareness Month, let's discuss what Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is.

MASLD, previously known as nonalcoholic fatty liver disease (NAFLD), is when fat builds up in your liver. MASLD is one of the most common forms of chronic liver disease and can cause more serious liver diseases without treatment. Read here to see if you show signs and symptoms, how providers diagnose MASLD, and treatment and prevention methods:

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common disease that happens when fat builds up in your liver. Having obesity and Type 2 diabetes increases your risk of MASLD. Learn more here.

10/24/2025

October is Liver Cancer Awareness Month, and one of the risk factors associated with liver cancer is having long-term hepatitis B and C infection. Get tested for hepatitis C and talk to your doctor about getting screened to help detect and prevent liver cancer. Read more about liver cancer here:

You can lower your risk of getting liver cancer in several ways.

10/22/2025

The ABCs of Hepatitis: What's the difference? When it comes to the Hepatitis virus, it is important to know what type of hepatitis virus you may have as each virus has different transmission and treatment routes. This graphic can help simplify the difference between Hepatitis A, B, and C. For more information, read here: https://healthtalk.unchealthcare.org/whats-the-difference-between-hepatitis-a-b-and-c-2/

10/22/2025

10/17/2025

Cirrhosis is the scarring of the liver tissue that causes permanent damage. When Hepatitis B/C is left untreated, it can lead to cirrhosis. However, not everyone with viral hepatitis will develop/know when cirrhosis develops. Talk to your provider if you show signs and symptoms.

10/15/2025

Did you know 1 in 3 Americans may have fatty liver disease and not even know it? A FibroScan is a quick, non-invasive ultrasound that checks for fat and scarring in your liver—it's pain-free and part of the essential standard of care.

At Arizona Liver Health, we make it easy to take charge of your liver health.

Here’s what you can expect:
FibroScan screenings available for new patients
Fast results reviewed by a liver specialist
Simple scheduling with flexible appointment options
Don’t wait for symptoms. Know your liver status and take control of your health today.

➡️ Tap the link in our bio to request your FibroScan appointment.

10/15/2025

Harm reduction has a significant role in reducing Hepatitis C infections, specifically among people who inject drugs (PWID). According to the Arizona Department of Health Services (ADHS), part of eliminating Hepatitis C in the state would involve an increase in programs that distribute safe and sterile supplies for Hepatitis C prevention. For more information, read ADHS Hepatitis C Elimination plan:

10/10/2025

Barriers to Hepatitis C Virus Care and How Federally Qualified Health Centers Can Improve Patient Access to Treatment

Despite the availability of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) treatment, disparities in HCV care and treatment persist for underserved populations due to demographic-based and insurance-based barriers. This study examines how these barriers can affect access to HCV treatment at for a federally qualified health center (FQHC) population:

Despite the availability of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) treatment, disparities in HCV care and treatment persist for underserved populations due to demographic-based and insurance-based barriers. We aim to ...

10/08/2025

October is National Substance Abuse Awareness Month, and it is important to discuss how people who use drugs (PWUD) are at risk of Hepatitis infection. Learn more about how to protect yourself when discussing with your provider:

Find information on testing and vaccination recommendations for people who use or inject drugs.

10/03/2025

Hepatitis D: What is it?
Hepatitis D is a liver infection caused by HDV and can only infect people who are also infected by the hepatitis B virus (HBV). As of July 2025, the World Health Organization (WHO) classifies Hepatitis D as carcinogenic. Read more:

As we mark World Hepatitis Day, WHO calls on governments and partners to urgently accelerate efforts to eliminate viral hepatitis as a public health threat and reduce liver cancer deaths.